Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$233M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| DeSilva Tara | Jan 12, 2024 | Buy | 1,800 | $0.58 | $1,000 |
| DeSilva Tara | Jan 12, 2024 | Buy | 466 | $0.56 | $260 |
| Cogley Brian | Jan 10, 2024 | Buy | 5,000 | $0.67 | $3,400 |
| Mehalick David | Jan 8, 2024 | Buy | 14,004 | $0.66 | $9,200 |
| Mehalick David | Jan 8, 2024 | Buy | 6,000 | $0.67 | $4,000 |
| Yerace Daniel Alexander | Jan 5, 2024 | Buy | 10,850 | $0.69 | $7,500 |
| Salkind Gene | Jan 5, 2024 | Buy | 11,600 | $0.69 | $8,000 |
| Mehalick David | Jan 5, 2024 | Buy | 5,050 | $0.69 | $3,500 |
| Cochran Christopher P. | Jan 5, 2024 | Buy | 7,000 | $0.77 | $5,400 |
| Salkind Gene | Aug 29, 2023 | Buy | 4,006 | $1.01 | $4,000 |
| Salkind Gene | Aug 25, 2023 | Buy | 28,638 | $0.91 | $26,000 |
| Calise Chris | Aug 23, 2023 | Buy | 9,000 | $0.94 | $8,500 |
| Calise Chris | Aug 23, 2023 | Buy | 2,582 | $0.9367 | $2,400 |
What's the latest insider transaction for Coeptis Therapeutics?
The most recent insider transaction for Coeptis Therapeutics was conducted by DeSilva Tara, who sold 1,800 shares on January 12, 2024 at a price of $0.58 per share.
Which insider bought the most COEP stock over the last two years?
Salkind Gene has bought the most COEP stock in the last 2 years, with a total value of $38,000.
What is the total value of insider transactions for Coeptis Therapeutics (COEP) in the last 2 years?
According to our estimates, the total value of insider transactions for Coeptis Therapeutics in the last 2 years is positive, amounting to $83,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Coeptis Therapeutics' market confidence?
Over the last 2 years, insider transactions for Coeptis Therapeutics have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
